+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

All Ages
All Genders
Healthy Volunteers
ID06831409

Study to Assess Heart Artery Disease Using CTA Scans in Former NFL Players

Led by HeartFlow, Inc. · Updated on 2025-08-26

300

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This research aims to assess the presence and severity of coronary artery disease CAD in retired NFL players. It is a post-market, multi-center observational study focusing on former NFL athletes who made either a practice squad or an active roster. The study will include around 300 participants from approximately 20 sites across the United States to better understand heart disease risks in this unique population. Participants will undergo Coronary Computed Tomography Angiography CCTA, a non-invasive imaging test that uses X-rays to produce detailed 3D images of the heart and its blood vessels, especially the coronary arteries. This diagnostic procedure helps identify coronary artery disease and plaque burden in the arteries. The study involves collecting and analyzing this imaging data to evaluate cardiac risk among NFL alumni. During the study, researchers will monitor participants CCTA results within 24 hours to identify those with CAD, physiologically significant CAD, and high coronary plaque burden. The data collection focuses on these heart health indicators, without any treatment intervention. Participation may involve completing the CCTA imaging and providing relevant health information, with the study expected to conclude by the end of 2026.

CONDITIONS

Brief Title

Using CTA Measures to Define Cardiac Risk In NFL Alumni

Research Team

H

HeartFlow

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here